Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCP + GnRH agonist vs estradiol valerate for pregnancy continuity after frozen embryo transfer
IRCT20120215009014N342Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of estradiol valerate and gonadotropin-releasing hormone agonist in infertility (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: pregnancy continuity after frozen embryo transfer. Started Jul 2019; status: completed.
02
Drugs
estradiol valerategonadotropin-releasing hormone agonist
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20120215009014N342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N342.